Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
70%
Coronavirus
37%
Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)
33%
Nsp14
33%
Nsp10
33%
Heavy Metal Contamination
33%
High-throughput Screen
33%
Non-structural Protein 14
33%
Bisubstrate Inhibitor
33%
Nsp3
33%
Methyltransferase
33%
Protease Assay
33%
Crystallographic Characterization
33%
Exonuclease Activity
33%
Palladium
13%
Passive Permeability
11%
Viral mRNA
11%
MTase
11%
Metabolic Stability
11%
Binding Site
11%
SAR Exploration
11%
Inhibition Response
11%
MRNA Cap
11%
Antiviral Activity
11%
Excellent Selectivity
11%
Structure-guided
11%
HepG2 Cytotoxicity
11%
Alphacoronavirus
11%
Enzyme Inhibition
11%
Methyltransferase Inhibitors
11%
Antiviral Target
11%
Phenotypic Response
11%
Cap-binding
11%
Methylation
11%
Structural Framework
11%
Guanine
11%
Underexploited
11%
Bisubstrate
11%
SARS-CoV-1
11%
X-ray Co-crystal Structure
11%
Protease Screening
6%
Chelating Resin
6%
Copper Contamination
6%
False Positive Hits
6%
PLpro
6%
Biochemical Assay
6%
Triage
6%
Metal Chelates
6%
Metal Salts
6%
Vulnerability
6%
Biochemistry, Genetics and Molecular Biology
SARS Coronavirus
100%
Structural Protein
66%
Methyltransferase
44%
Exonuclease
33%
Protease
33%
Coronavirinae
33%
Cofactor
22%
RNA
19%
Methylation
19%
Crystal Structure
19%
RNA Replication
11%
Ternary Complex
11%
N-Terminus
11%
Polymerase
11%
Translation Initiation
11%
Nucleotide
11%
Drug Development
11%
Alphacoronavirus
8%
Cytotoxicity
8%
Messenger RNA
8%
Binding Site
8%
X Ray
8%
Structure Activity Relationship
8%
Guanine
8%
Enzyme Inhibition
8%
Antiviral Activity
8%
Copurification
6%
Bioassay
6%
Enzyme
6%
Immunology and Microbiology
Severe Acute Respiratory Syndrome Coronavirus 2
66%
Methylation
33%
Susceptibility
33%
Translation Initiation
33%
Amino Terminal Sequence
33%
Crystal Structure
33%
Coronavirus
33%
Structural Protein
33%
RNA Replication
33%
Proteinase
33%
Protease
33%
SARS Coronavirus
33%
Ribonucleic Acid
33%
